Novel Inhibitors for MDM2-MDM4 E3 Ligase Potently Induce p53-Indepedent Apoptosis in Drug-Resistant Leukemic Cells
MDM2 and MDM4 are major negative regulators of tumor suppressor p53. Beyond regulating p53, MDM2 possesses p53-independent activity in promoting cell cycle progression and tumorigenesis via its RING domain ubiquitin E3 ligase activity. MDM2 and MDM4 form heterodimer polyubiquitin E3 ligases via thei...
Saved in:
Main Authors: | Rati Lama, Joseph M. Fose, Diana Martín, Inés G. Muñoz, Eunice S. Wang, Pamela J. Sung, Sherry R. Chemler, Xinjiang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/30/1/186 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ezetimibe Anticancer Activity via the p53/Mdm2 Pathway
by: Charmy Twala, et al.
Published: (2025-01-01) -
CENPN contributes to pancreatic carcinoma progression through the MDM2-mediated p53 signaling pathway
by: Ming Xu, et al.
Published: (2024-04-01) -
Primary liposarcoma of the uterus with MDM2 negative
by: Shufei Wei, et al.
Published: (2024-12-01) -
Tumor hypoxia evidences the differential regulation of Mdm2-p53 axis by PTEN in tumor derived vs. normal endothelial cells
by: Kinga Wilkus-Adamczyk, et al.
Published: (2024-12-01) -
Association between ТР53, MDM2 and NQO1 gene polymorphisms and viral load among women with human papillomavirus
by: A.H. AlBosale, et al.
Published: (2022-03-01)